What Relay Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 13 | 41 |
| Total trades | 13 | 50 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 272,802 |
| Disposed | 6,215,230 | 6,927,056 |
| Net activity | −6,215,230 | −6,654,254 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Patel Sanjiv | President and CEO | Oct 07 | Open-market sale · S | −48,199 | $18.10 | −$872K | 471,301 |
| Catinazzo Thomas | Chief Financial Officer | Oct 06 | Open-market sale · S | −206 | $19.26 | −$3.97K | 105,134 |
| Catinazzo Thomas | Chief Financial Officer | Oct 06 | Open-market sale · S | −17,511 | $18.58 | −$325K | 105,340 |
| Patel Sanjiv | President and CEO | Sep 08 | Open-market sale · S | −48,199 | $18.94 | −$913K | 519,500 |
| Catinazzo Thomas | Chief Financial Officer | Sep 08 | Open-market sale · S | −17,717 | $18.94 | −$336K | 122,851 |
| Bergstrom Donald A | President, R&D | Sep 08 | Open-market sale · S | −8,530 | $18.97 | −$162K | 399,130 |
| Rahmer Peter | See remarks | Aug 26 | Open-market sale · S | −4,508 | $20.03 | −$90.3K | 223,657 |
| Svf Pauling (Cayman) Ltd | 10% owner | Aug 25 | Open-market sale · S | −6,000,000 | $19.40 | −$116M | 21,904,963 |
| Patel Sanjiv | President and CEO | Aug 17 | Open-market sale · S | −48,199 | $20.33 | −$980K | 567,699 |
| Catinazzo Thomas | Chief Financial Officer | Aug 14 | Open-market sale · S | −17,717 | $19.74 | −$350K | 140,568 |
| Rahmer Peter | See remarks | Jul 28 | Sale for tax withholding · S | −748 | $18.61 | −$13.9K | 228,165 |
| Bergstrom Donald A | President, R&D | Jul 28 | Sale for tax withholding · S | −2,237 | $18.61 | −$41.6K | 407,660 |
| Catinazzo Thomas | Chief Financial Officer | Jul 28 | Sale for tax withholding · S | −1,459 | $18.61 | −$27.2K | 158,285 |
| Patel Sanjiv | President and CEO | Jul 07 | Open-market sale · S | −48,199 | $19.58 | −$944K | 615,898 |
| Bergstrom Donald A | President, R&D | Jul 06 | Open-market sale · S | −8,660 | $18.71 | −$162K | 409,897 |
| Catinazzo Thomas | Chief Financial Officer | Jul 06 | Open-market sale · S | −17,717 | $18.69 | −$331K | 159,744 |
| Rahmer Peter | See remarks | Jun 30 | Grant / award · A | +3,056 | $6.95 | +$21.2K | 228,913 |
| Rahmer Peter | See remarks | Jun 30 | Open-market sale · S | −50,000 | $19.09 | −$955K | 225,857 |
| Patel Sanjiv | President and CEO | Jun 30 | Grant / award · A | +3,056 | $6.95 | +$21.2K | 664,097 |
| Bergstrom Donald A | President, R&D | Jun 22 | Open-market sale · S | −93,456 | $16.94 | −$1.58M | 418,557 |
Loading...
